Document is current
Any future updates will be listed below
-
Authors
Feleke, Rahel
Reynolds, Regina H.
Smith, Amy M.
Tilley, Bension
Taliun, Sarah A. Gagliano
Hardy, John
Matthews, Paul M.
Gentleman, Steve
Owen, David R.
Johnson, Michael R.
Srivastava, Prashant K.
Ryten, Mina
-
Funding
Funding for this research was provided by:
Wolfson Foundation
Signe og Peter Gregersens Mindefond
Fonds de Recherche du Québec - Santé (Junior 1 award)
UK Dementia Research Institute
UKRI Medical Research Council (MR/N026004/, MR/N008219/1, MR/S02638X/1, MR/S02638X/1, MR/N008324/1, MR/S02638X/1)
UK Dementia Research Institute
Wellcome Trust (202903/Z/16/Z)
Dolby Family Fund
National Institute for Health Research
NIHR Imperial Biomedical Research Centre
Edmond J. Safra Philanthropic Foundation
Parkinson's UK
- License Information
-
More Information
Article History
Received: 22 April 2021
Revised: 22 June 2021
Accepted: 1 July 2021
First Online: 26 July 2021
Declarations
:
: RHR, RF, AMS, BT, SAGT, JH, SG, DRO, MRJ, PKS and MR declare that they have no relevant financial or non-financial interests to disclose. PMM has received honoraria or consulting fees from Biogen, Novartis, Ipsen Pharmaceuticals, NodThera and Celgene. He receives research funding from Biogen, Merck, Celgene and Bristol Myers Squibb.
: Ethics approval for the work carried out on the tissue from the Multiple Sclerosis and Parkinson’s Tissue Bank was given by Wales REC3 ethic committee, REC reference 18/WA/0238.
